Form 8-K - Current report:
SEC Accession No. 0001654954-19-005691
Filing Date
2019-05-10
Accepted
2019-05-10 16:30:21
Documents
5
Period of Report
2019-05-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cdxc8k_may92019.htm 8-K 43260
2 NOTE PURCHASE AGREEMENT, DATED MAY 9, 2019, BY AND AMONG THE COMPANY AND THE PUR ex99-1.htm EX-99.1 321399
3 REGISTRATION RIGHTS AGREEMENT, DATED MAY 9, 2019, BY AND AMONG THE COMPANY AND T ex99-2.htm EX-99.2 159268
4 PRESS RELEASE ex99-3.htm EX-99.3 15438
5 IMAGE chromadexlogo.jpg GRAPHIC 3990
  Complete submission text file 0001654954-19-005691.txt   546244
Mailing Address 10900 WILSHIRE BLVD SUITE 650 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 650 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Filer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37752 | Film No.: 19815395
SIC: 2833 Medicinal Chemicals & Botanical Products